Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Windward Bio (Nasdaq: WWB), a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. The initial public offering (IPO) was priced at $17.00 per share, and its shares closed at $28.50 on the first trading day, marking a 68% increase and giving the company a market capitalization of approximately $1.69 billion.